Real-World Study on Chinese Medicine for Treating Chikungunya Fever
Recruiting now
Conditions studied: Chikungunya Fever
In brief
This study aims to evaluate the effectiveness and safety of Chinese Medicine-used alone or combined with Western medicine-in treating chikungunya fever, a mosquito-borne viral disease causing fever, rash, and severe joint pain. With recent outbreaks in China (including over 3,000 cases in Foshan, Guangdong) and no specific antiviral treatment available, Chinese medicine may offer a valuable therapeutic option based on its symptom-relief and syndrome-specific approach.
Key facts
- Study ID
- NCT07120724
- Run by
- Guangzhou University of Traditional Chinese Medicine
- People needed
- 600
- Starts
- 2025-07-26
- Expected to finish
- 2026-12-26
- Last updated by the study team
- 2025-08-13
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Meets the suspected or confirmed diagnostic criteria for chikungunya fever;
- Symptom onset ≤3 days before enrollment;
- Actual prescribed treatment aligns with the study's group assignment (TCM, Western medicine, or combined therapy)
- Signed informed consent form
You may not qualify if…
- Severe chikungunya fever;
- Participation in another drug clinical trial within the past 3 months;
- Any other condition deemed by the investigator as unsuitable for enrollment.
Where it is running
- Guangdong Province Hospital of Tradtional Chinese Medicine — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.